Osipova N A, Beresnev V A, Vetsheva M S, Dolgopolova T V
Anesteziol Reanimatol. 1999 Nov-Dec(6):71-4.
A prophylactic approach to the management of postoperative pain is described: ketoprofen, a nonsteroid antiinflammatory drug, was used, which possesses numerous advantages and a variety of dosage forms. To cancer patients subjected to extensive radical operations on the pelvic organs, head, and neck, ketonal (ketoprofen) was injected intramuscularly or rectally in a dose of 100 mg 1 h before surgery and in a daily dose of 300 mg during the postoperative period. Adequate postoperative monoanalgesia with ketonal was attained in 47% patients. In the rest patients ketonal was combined with medium-potent opioid tramadol. A more potent opioid buprenorfin (sangesik) in the minimal daily dose of 0.3 mg was required in only 2 cases. Nonsteroid antiinflammatory drug ketoprofen (ketonal) in therapeutic doses administered preventively before surgery intramuscularly or rectally notably decreased the acuity of the postoperative pain syndrome.
使用了酮洛芬,一种非甾体抗炎药,它具有众多优点和多种剂型。对于接受盆腔器官、头部和颈部广泛根治性手术的癌症患者,在手术前1小时肌肉注射或直肠给药酮咯酸(酮洛芬)100mg,术后每日剂量为300mg。47%的患者通过酮咯酸获得了充分的术后单药镇痛效果。其余患者中,酮咯酸与中效阿片类药物曲马多联合使用。仅2例患者需要最低日剂量0.3mg的更强效阿片类药物丁丙诺啡(善思康)。术前预防性肌肉注射或直肠给药治疗剂量的非甾体抗炎药酮洛芬(酮咯酸)显著降低了术后疼痛综合征的严重程度。